Critical design considerations for time-to-event endpoints in amyotrophic lateral sclerosis clinical trials. (2019)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/jnnp-2019-320998
PubMed Identifier: 31292200
Publication URI: http://europepmc.org/abstract/MED/31292200
Type: Journal Article/Review
Volume: 90
Parent Publication: Journal of neurology, neurosurgery, and psychiatry
Issue: 12
ISSN: 0022-3050